A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma
Clinical trial NCT03711188 · COMPLETED
Trial details
- NCT number
- NCT03711188
- Sponsor
- Immodulon Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2021-12-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.